ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Hongqin Ma, Lulu Kong, Li Liu, Yusheng Du, Xinguo Zhu, Ji Wang, Wenxing Zhao |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
by: Yecheng Li, et al.
Published: (2024)
by: Yecheng Li, et al.
Published: (2024)
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
by: Keping Deng, et al.
Published: (2024)
by: Keping Deng, et al.
Published: (2024)
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
by: Anna Han, et al.
Published: (2024)
by: Anna Han, et al.
Published: (2024)
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
by: Yunyun Liu, et al.
Published: (2024)
by: Yunyun Liu, et al.
Published: (2024)
Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways
by: Kewei Song, et al.
Published: (2024)
by: Kewei Song, et al.
Published: (2024)
Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
by: Xing Ma, et al.
Published: (2024)
by: Xing Ma, et al.
Published: (2024)
Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
by: Qun Chen, et al.
Published: (2024)
by: Qun Chen, et al.
Published: (2024)
Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression
by: Waseem Raza, et al.
Published: (2024)
by: Waseem Raza, et al.
Published: (2024)
Combined treatment with Aronia berry extract and oligomeric proanthocyanidins exhibit a synergistic anticancer efficacy through LMNB1‐AKT signaling pathways in colorectal cancer
by: Yuan Li, et al.
Published: (2024)
by: Yuan Li, et al.
Published: (2024)
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
by: Xiaoyu Xiong, et al.
Published: (2024)
by: Xiaoyu Xiong, et al.
Published: (2024)
C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer
by: Bo Liu, et al.
Published: (2024)
by: Bo Liu, et al.
Published: (2024)
Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling
by: Jing Peng, et al.
Published: (2024)
by: Jing Peng, et al.
Published: (2024)
STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway
by: Junyi Jin, et al.
Published: (2024)
by: Junyi Jin, et al.
Published: (2024)
AOC3 Loss Promotes Imatinib Resistance in GIST by Stabilizing HK2 and Enhancing H3K18la‐Driven Myc Transcription
by: Zhiyuan Guo, et al.
Published: (2026)
by: Zhiyuan Guo, et al.
Published: (2026)
The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway
by: Runqi Hong, et al.
Published: (2024)
by: Runqi Hong, et al.
Published: (2024)
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway
by: Junfeng Li, et al.
Published: (2024)
by: Junfeng Li, et al.
Published: (2024)
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
by: Junqi Wang, et al.
Published: (2024)
by: Junqi Wang, et al.
Published: (2024)
SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma
by: Pingping Xiao, et al.
Published: (2024)
by: Pingping Xiao, et al.
Published: (2024)
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
by: Fangquan Chen, et al.
Published: (2024)
by: Fangquan Chen, et al.
Published: (2024)
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer
by: Qi Zhang, et al.
Published: (2024)
by: Qi Zhang, et al.
Published: (2024)
MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer
by: Pengpeng Liu, et al.
Published: (2024)
by: Pengpeng Liu, et al.
Published: (2024)
TOP2A, Stabilized by IGF2BP3 in an m6A‐Dependent Manner, Drives Macrophage Recruitment and M2 Polarization in Hepatocellular Carcinoma by YAP1‐Mediated CCL2 Activation
by: Lu Li, et al.
Published: (2025)
by: Lu Li, et al.
Published: (2025)
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B
by: Qianjin Zhang, et al.
Published: (2024)
by: Qianjin Zhang, et al.
Published: (2024)
Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway
by: Min‐Jie Zhang, et al.
Published: (2024)
by: Min‐Jie Zhang, et al.
Published: (2024)
Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling
by: Yun Dong, et al.
Published: (2024)
by: Yun Dong, et al.
Published: (2024)
MAZ Coordinates With HDAC1 to Promote Hepatocarcinoma Proliferation and Metastasis Through Transcriptional Repression of CSK
by: Rongfang Qiu, et al.
Published: (2025)
by: Rongfang Qiu, et al.
Published: (2025)
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
by: Hao Zhu, et al.
Published: (2024)
by: Hao Zhu, et al.
Published: (2024)
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity
by: Kieun Bae, et al.
Published: (2024)
by: Kieun Bae, et al.
Published: (2024)
Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression
by: Ji Li, et al.
Published: (2024)
by: Ji Li, et al.
Published: (2024)
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
by: Takashi Furusawa, et al.
Published: (2024)
by: Takashi Furusawa, et al.
Published: (2024)
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis
by: Shashikanta Sahoo, et al.
Published: (2024)
by: Shashikanta Sahoo, et al.
Published: (2024)
M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination
by: Ping Yin, et al.
Published: (2024)
by: Ping Yin, et al.
Published: (2024)
Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity
by: Shaofei Liu, et al.
Published: (2024)
by: Shaofei Liu, et al.
Published: (2024)
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer
by: Rosalin Mishra, et al.
Published: (2024)
by: Rosalin Mishra, et al.
Published: (2024)
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway
by: Qihong Cai, et al.
Published: (2024)
by: Qihong Cai, et al.
Published: (2024)
Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression
by: Yunho Jin, et al.
Published: (2024)
by: Yunho Jin, et al.
Published: (2024)
The RNA‐binding protein sorbin and SH3 domain‐containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor
by: Beibei Wang, et al.
Published: (2024)
by: Beibei Wang, et al.
Published: (2024)
Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival
by: Xiaoxia Tong, et al.
Published: (2024)
by: Xiaoxia Tong, et al.
Published: (2024)
NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple‐negative breast cancer by blocking the EGFR pathway
by: Rui Sang, et al.
Published: (2024)
by: Rui Sang, et al.
Published: (2024)
FAP positive cancer‐associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1‐AS1
by: Xilei Zhou, et al.
Published: (2024)
by: Xilei Zhou, et al.
Published: (2024)
Similar Items
-
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
by: Yecheng Li, et al.
Published: (2024) -
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
by: Keping Deng, et al.
Published: (2024) -
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
by: Anna Han, et al.
Published: (2024) -
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
by: Yunyun Liu, et al.
Published: (2024) -
Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways
by: Kewei Song, et al.
Published: (2024)